Immune checkpoint inhibitor (ICI) therapy before surgery for hepatocellular carcinoma (HCC) may produce major pathological ...

In a multi-institutional study published today in Nature Nanotechnology, researchers from The University of Texas MD Anderson ...

A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published in Nature ...

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis - a ...

Jo Varshney, PhD, DVM, discusses how VeriSIM Life’s innovative approach leverages artificial intelligence and multispecies ...

- Single-dose administration of LAE102 by IV or SC injection demonstrated a favorable safety profile in the healthy participants as well as robust and prolonged target engagement in the healthy ...

Raanana, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (PLRZ) Polyrizon Ltd. (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective ...

The hormone estrogen regulates binge drinking in females, causing them to 'pregame' -- consume large quantities of alcohol in the first 30 minutes after it's offered, according to a preclinical study.

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases ...

Silo Pharma, Inc. has announced the start of a pharmacokinetic and tolerability study for its novel, non-opioid extended-release pain therapeutic, SP-26, in collaboration with AmplifyBio. The study ...